About webadmin@phasesci.com

This author has not yet filled in any details.
So far webadmin@phasesci.com has created 29 blog entries.

Update on SCOTUS and the COVID-19 Vaccine Testing Mandate

No, for Businesses. Yes, for Healthcare Providers

Effective January 26, the US government has formally withdrawn its vaccine and testing mandate for businesses after the Supreme Court ruled that the Occupational Safety and Health Administration (OSHA) had exceeded its authority.

The Supreme Court, in a 6-3 decision made on January 13, blocked […]

Update on SCOTUS and the COVID-19 Vaccine Testing Mandate2022-02-09T01:25:49+05:00

SCOTUS Block on OSHA’s Emergency Temporary Standard

Two Giants in A Tug-Of-War

We all saw it coming. As soon as the Occupational Safety and Health Administration (OSHA) issued the Emergency Temporary Standard (ETS) on COVID-19 Vaccination and Testing, the pushback has caused an uproar in both private and public sectors.

Because of all the suits filed since the mandate, the […]

SCOTUS Block on OSHA’s Emergency Temporary Standard2022-01-20T21:21:16+05:00

OSHA Vaccine Mandate

FULL COMPLIANCE WENT INTO EFFECT ON JANUARY 4, 2022

As of December 17, the U.S. Court of Appeals for the Sixth Circuit in Cincinnati overturned the Fifth Circuit’s ruling, blocking OSHA’s vaccine/testing mandate. This OSHA rule states that businesses of 100 or more employees must require vaccinations for their workers by January […]

OSHA Vaccine Mandate2022-01-07T07:15:07+05:00

Phase Scientific Charters Planes to Fly Tests To The US

Phase Scientific recently needed to get their much needed Covid-19 Rapid Antigen test Kits to the United State for distribution. unable to secure transportation commercially, Phase Scientific chartered planes on their own to get their tests in the hands of Americans.

The tests arrived in Los Angeles, California, and were quickly offloaded […]

Phase Scientific Charters Planes to Fly Tests To The US2022-02-14T21:59:56+05:00

EUA for INDICAID® to Cover Serial Testing for Asymptomatic Individuals

The US FDA has extended their emergency use authorization (EUA) for the INDICAID COVID-19 Rapid Antigen Test to cover serial testing for asymptomatic individuals in a recent update.

The update extends the use of INDICAID as a screening test, providing an additional accurate and reliable testing option for schools, workplaces, and communities.

“We […]
EUA for INDICAID® to Cover Serial Testing for Asymptomatic Individuals2022-02-03T23:41:46+05:00

What is the message for employers dealing with Omicron and other variants?

If there is one thing this pandemic can teach us, it is to expect the unexpected. However, using the information we have gathered on viruses from pandemics of the past, we have learned that future variants, and pandemics for that matter, are to be expected. So long as viruses are left […]

What is the message for employers dealing with Omicron and other variants?2022-01-05T19:34:06+05:00

INDICAID® COVID-19 Rapid Antigen Test Receives EUA From the U.S. FDA

GARDEN GROVE, Calif.Aug. 10, 2021 /PRNewswire/ — PHASE Scientific International LTD (PHASE Scientific), today announced that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on July 29, 2021.

The FDA authorized the test for professional use […]

INDICAID® COVID-19 Rapid Antigen Test Receives EUA From the U.S. FDA2022-03-18T21:45:07+05:00

Phase Scientific Donates Tests to International Community

PHASE Scientific and Vattanac Group jointly donated 100,000 INDICAID COVID-19 Rapid Antigen Test Kits to the Royal Government of Cambodia to support their effort to fight against the pandemic in the country. Seng Teang, Secretary of State in the Office of the Prime Minister attended the handover ceremony. Prime Minister Hun Sen […]

Phase Scientific Donates Tests to International Community2022-01-05T19:46:55+05:00

Evaluation of the INDICAID® in Symptomatic and Asymptomatic Community Testing

The global SARS-CoV-2 pandemic has continued despite implementation of significant public health measures (1). Over 155 million worldwide cases of COVID-19 and over 3 million COVID-19 deaths have been reported as of May 2021. Rapid identification of SARS-CoV-2 infection, patient isolation, and contact tracing are essential for disease containment (2). The […]

Evaluation of the INDICAID® in Symptomatic and Asymptomatic Community Testing2022-02-14T21:59:11+05:00
Go to Top